Skip to content

Member

Adam JARUBAS

EPP · Poland

Group
EPP PPE
Country
Poland
Roll-call participation
76.9 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
95.0 %ⓘ of 477 votes where the group had a line · EPP median 95.6 %
More facts (5)
National party
PSL Polskie Stronnictwo Ludowe
In office
Since 16 Jul 2024
Against clear line
14 of 452 votesⓘ
Committees
ENVI (substitute), ITRE, SANT (chair)
Member id
197517
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

76.9 %

477 of 620 final votes while in office

EPP median: 90.6 % (−13.6 pts)

Chamber median: 90.6 %

With majority line ⓘ

95.0 %

453 of 477 votes where their group had a line

EPP median: 95.6 % (−0.6 pts)

Against clear line ⓘ

3.1 %

14 of 452 votes where their group had a clear line

8 opposite (for ↔ against), 6 abstained against the line

Abstention ⓘ

2.3 %

11 of 477 votes cast

Participation 76.9 % — EPP median 90.6 %, 192 members.ⓘ
Data as a table
Participation among the 192 members of the EPP with enough votes.
FigureParticipation
Adam JARUBAS76.9 %
EPP median90.6 %
Lowest in the group18.4 %
Highest in the group99.8 %
Members192
With majority line 95.0 % — EPP median 95.6 %, 192 members.ⓘ
Data as a table
With majority line among the 192 members of the EPP with enough votes.
FigureWith majority line
Adam JARUBAS95.0 %
EPP median95.6 %
Lowest in the group67.8 %
Highest in the group99.0 %
Members192
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
23 Jan 2025Russia’s disinformation and historical falsification to justify its war of aggression against Ukraine Adopted 480 for, 58 against, 48 abstainedPosition: No vote recorded Majority line: For
23 Jan 2025Situation in Venezuela following the usurpation of the presidency on 10 January 2025 Adopted 374 for, 53 against, 163 abstainedPosition: No vote recorded Majority line: For
22 Jan 2025Need for actions to address the continued oppression and fake elections in Belarus Adopted 567 for, 25 against, 66 abstainedPosition: For Majority line: For
21 Jan 2025EU/Republic of Serbia agreement on operational activities carried out by the European Border and Coast Guard Agency in the Republic of Serbia Consent given 505 for, 90 against, 43 abstainedPosition: For Majority line: For
19 Dec 2024Amending Directive 2009/38/EC as regards the establishment and functioning of European Works Councils and the effective enforcement of transnational information and consultation rights Negotiating mandate approved 300 for, 254 against, 21 abstainedPosition: No vote recorded Majority line: Against
19 Dec 2024Human rights situation in Kyrgyzstan, in particular the case of Temirlan Sultanbekov Adopted 492 for, 28 against, 41 abstainedPosition: No vote recorded Majority line: For
19 Dec 202411th year of the occupation of the Autonomous Republic of Crimea and the city of Sevastopol by the Russian Federation and the deteriorating human rights situation in occupied Crimea, notably the cases of Iryna Danylovych, Tofik Abdulhaziiev and Amet Suleymanov Adopted 446 for, 25 against, 51 abstainedPosition: No vote recorded Majority line: For
19 Dec 2024Continued repression of civil society and independent media in Azerbaijan and the cases of Dr Gubad Ibadoghlu, Anar Mammadli, Kamran Mammadli, Rufat Safarov and Meydan TV Adopted 434 for, 30 against, 89 abstainedPosition: No vote recorded Majority line: For
19 Dec 2024Recommendation to the Council on the EU priorities for the 69th session of the UN Commission on the Status of Women Adopted 322 for, 163 against, 46 abstainedPosition: No vote recorded Majority line: For
18 Dec 2024EC-Pacific States Interim Partnership Agreement: accession of Tonga Consent given 545 for, 81 against, 26 abstainedPosition: For Majority line: For
18 Dec 2024EC-Pacific States Interim Partnership Agreement: accession of Niue Consent given 543 for, 77 against, 31 abstainedPosition: For Majority line: For
18 Dec 2024Conclusion, on behalf of the European Union, of the United Nations Convention on Transparency in Treaty-based Investor-State Arbitration Consent given 591 for, 7 against, 53 abstainedPosition: For Majority line: For
18 Dec 2024EC-Pacific States Interim Partnership Agreement: accession of Tuvalu Consent given 533 for, 74 against, 26 abstainedPosition: For Majority line: For
18 Dec 2024Amendment of Annex VI – Powers and responsibilities of the standing committees Adopted 448 for, 161 against, 40 abstainedPosition: For Majority line: For
18 Dec 2024Setting up a Special Committee on the European Democracy Shield, and defining its responsibilities, numerical strength and term of office Adopted 441 for, 178 against, 34 abstainedPosition: For Majority line: For
18 Dec 2024Setting up a Special Committee on the Housing Crisis in the European Union, and defining its responsibilities, numerical strength and term of office Adopted 480 for, 148 against, 20 abstainedPosition: For Majority line: For
17 Dec 2024Deforestation Regulation: provisions relating to the date of application Passed 546 for, 97 against, 7 abstainedPosition: For Majority line: For
17 Dec 2024Specific measures under the European Agricultural Fund for Rural Development (EAFRD) for Member States affected by natural disasters Passed 644 for, 6 against, 3 abstainedPosition: For Majority line: For
17 Dec 2024Regional Emergency Support: RESTORE Passed 638 for, 10 against, 5 abstainedPosition: For Majority line: For
17 Dec 2024Forest reproductive material of the ‘tested’ category Passed 499 for, 131 against, 27 abstainedPosition: For Majority line: For
17 Dec 2024Mobilisation of the European Globalisation Adjustment Fund: application EGF/2024/002 BE/Limburg machinery and paper – Belgium Passed 599 for, 50 against, 7 abstainedPosition: For Majority line: For
17 Dec 2024Activities of the European Ombudsman – annual report 2023 Adopted 598 for, 17 against, 37 abstainedPosition: For Majority line: For
28 Nov 2024Hong Kong, notably the cases of Jimmy Lai and the 45 activists recently convicted under the national security law Adopted 473 for, 23 against, 98 abstainedPosition: No vote recorded Majority line: For
28 Nov 2024The increasing and systematic repression of women in Iran Adopted 562 for, 2 against, 30 abstainedPosition: No vote recorded Majority line: For
28 Nov 2024The shrinking space for civil society in Cambodia, in particular the case of the labour rights organisation CENTRAL Adopted 492 for, 5 against, 102 abstainedPosition: No vote recorded Majority line: For
28 Nov 2024Georgia's worsening democratic crisis following the recent parliamentary elections and alleged electoral fraud Adopted 444 for, 72 against, 82 abstainedPosition: No vote recorded Majority line: For
28 Nov 2024Reinforcing EU’s unwavering support to Ukraine against Russia’s war of aggression and the increasing military cooperation between North Korea and Russia Adopted 390 for, 135 against, 52 abstainedPosition: No vote recorded Majority line: For
28 Nov 2024Recommendation on smoke- and aerosol-free environments Rejected 152 for, 378 against, 26 abstainedPosition: No vote recorded Majority line: For
27 Nov 2024Amending Regulation (EU) 2018/1806 as regards Vanuatu Passed 627 for, 6 against, 37 abstainedPosition: For Majority line: For
27 Nov 2024Mobilisation of the European Union Solidarity Fund to provide assistance to Germany and Italy relating to floods occurred in 2024 Passed 660 for, 11 against, 4 abstainedPosition: For Majority line: For
27 Nov 2024Draft amending budget No 5/2024: adjustment in payment appropriations, update of revenues and other technical updates Passed 525 for, 75 against, 81 abstainedPosition: For Majority line: For
27 Nov 2024Measures to reduce incidental catches of common dolphin (Delphinus delphis) and other small cetaceans in the Bay of Biscay Objection failed 123 for, 511 against, 42 abstainedPosition: Against Majority line: Against
27 Nov 20242025 budgetary procedure: Joint text Adopted 418 for, 185 against, 67 abstainedPosition: For Majority line: For
27 Nov 2024Presentation by the President-elect of the Commission of the College of Commissioners and its programme Rejected 154 for, 507 against, 19 abstainedPosition: Against Majority line: Against
27 Nov 2024Election of the Commission Commission elected 370 for, 282 against, 36 abstainedPosition: For Majority line: For
26 Nov 2024Genetically modified maize MON 89034 × 1507 × NK603 Objection passed 474 for, 171 against, 13 abstainedPosition: No vote recorded Majority line: Against
26 Nov 2024Genetically modified cotton COT102 Objection passed 496 for, 143 against, 18 abstainedPosition: No vote recorded Majority line: Against
26 Nov 2024Genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 and eight of its sub-combinations Objection passed 476 for, 169 against, 14 abstainedPosition: No vote recorded Majority line: Against
26 Nov 2024Genetically modified maize MON 810 Objection passed 464 for, 163 against, 27 abstainedPosition: No vote recorded Majority line: Against
26 Nov 2024Genetically modified maize DP915635 Objection passed 478 for, 166 against, 17 abstainedPosition: No vote recorded Majority line: Against
26 Nov 2024Genetically modified maize DP23211 Objection passed 474 for, 166 against, 17 abstainedPosition: No vote recorded Majority line: Against
26 Nov 2024Genetically modified maize DP202216 Objection passed 478 for, 165 against, 16 abstainedPosition: No vote recorded Majority line: Against
26 Nov 2024Genetically modified maize MON 94804 Objection passed 468 for, 166 against, 14 abstainedPosition: No vote recorded Majority line: Against
14 Nov 2024Deforestation Regulation: provisions relating to the date of application Passed 371 for, 240 against, 30 abstainedPosition: For Majority line: For
14 Nov 2024Electronic value added tax exemption certificate Passed 621 for, 10 against, 11 abstainedPosition: For Majority line: For
14 Nov 2024Faster and Safer Relief of Excess Withholding Taxes Passed 555 for, 48 against, 42 abstainedPosition: For Majority line: For
14 Nov 2024Amendment of the EIB’s Statute Passed 510 for, 105 against, 27 abstainedPosition: For Majority line: For
14 Nov 2024UN Climate Change Conference 2024 in Baku, Azerbaijan (COP29) Adopted 429 for, 183 against, 24 abstainedPosition: For Majority line: For
24 Oct 2024Situation in Azerbaijan, violation of human rights and international law and relations with Armenia Adopted 453 for, 31 against, 89 abstainedPosition: For Majority line: For
24 Oct 2024People’s Republic of China’s misinterpretation of the UN resolution 2758 and its continuous military provocations around Taiwan Adopted 432 for, 60 against, 71 abstainedPosition: For Majority line: For

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 19 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Krzysztof HETMAN EPPPoland96 % of 4 016 shared89 %
Jacek PROTAS EPPPoland95 % of 4 257 shared89 %
Marta WCISŁO EPPPoland95 % of 4 353 shared89 %
Bogdan Andrzej ZDROJEWSKI EPPPoland95 % of 4 363 shared89 %
Andrzej BUŁA EPPPoland95 % of 4 003 shared89 %
Kamila GASIUK-PIHOWICZ EPPPoland94 % of 4 317 shared89 %
Dariusz JOŃSKI EPPPoland94 % of 4 334 shared89 %
Bartosz ARŁUKOWICZ EPPPoland94 % of 4 178 shared89 %
Andrzej HALICKI EPPPoland94 % of 4 105 shared89 %
Bartłomiej SIENKIEWICZ EPPPoland94 % of 4 317 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Eugen TOMAC RenewRomania81 % of 3 166 shared82 %
Katri KULMUNI RenewFinland81 % of 3 539 shared82 %
Urmas PAET RenewEstonia81 % of 3 836 shared82 %
Dan BARNA RenewRomania80 % of 3 840 shared82 %
Hilde VAUTMANS RenewBelgium80 % of 4 231 shared82 %
Marie-Pierre VEDRENNE Former memberRenewFrance80 % of 1 976 shared82 %
Bart GROOTHUIS RenewNetherlands79 % of 3 307 shared82 %
Jeannette BALJEU RenewNetherlands79 % of 3 942 shared82 %
Ivars IJABS RenewLatvia79 % of 3 424 shared82 %
Benoit CASSART RenewBelgium79 % of 4 014 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeChair29 Jan 2025now
Delegation for relations with the People's Republic of ChinaD-CN DelegationMember19 Sept 2024now
Delegation for relations with the Korean PeninsulaDKOR DelegationSubstitute19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeSubstitute19 Jul 202419 Jan 2025
Committee on Public HealthSANT CommitteeMember23 Jan 202528 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeChair23 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202422 Jul 2024

Show all 10 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
EU Emissions Trading System: heat and fuel benchmark values for 2026–2030RapporteurENVI2 Sept 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsRapporteurSANT16 Apr 2026
24th EU-Republic of South Korea Interparliamentary Meeting\nSeoul 27-29 May 2026Official delegationDKOR16 Apr 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measuresShadow rapporteurENVI16 Apr 2026
No dossier namedOfficial delegationSANT24 Mar 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measuresShadow rapporteurENVI24 Mar 2026
Laying down the multiannual financial framework for the years 2028 to 2034Opinion rapporteurSANT11 Feb 2026
Guidelines for the 2027 Budget - Section IIIOpinion rapporteurSANT11 Feb 2026
No dossier namedOfficial delegationSANT28 Jan 2026
No dossier namedOfficial delegationSANT9 Oct 2025

Show all 14 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

14 contributions recorded; 2 on behalf of their group; 23 minutes of speaking time.

Show all 14 recent contributions

Questions and motions, 29

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
22 Jun 2026SCoPAFF’s reclassification of plant protection products E-10-2026-002564Written questionwith 1 co-authorNot yet answered
17 Jun 2026Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516Written questionwith 17 co-authors24 Aug 2026
25 Mar 2026Ensuring competition and strategic autonomy in the AI gigafactory supply chain E-10-2026-001255Written questionwith 17 co-authors19 Jun 2026
24 Feb 2026Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762Written questionwith 20 co-authors16 Apr 2026
18 Feb 2026Inspections to ensure regulatory conformity of cosmetic products in the single market with the Cosmetic Products Regulation E-10-2026-000687Written questionwith 22 co-authorsNot yet answered
18 Feb 2026Checks on the presence of prohibited substances and trace impurities in non-EU cosmetic products entering the single market E-10-2026-000688Written questionwith 21 co-authors21 May 2026
13 Feb 2026Commission proceedings concerning complaint CPLT(2023)02625 on Poland’s restrictions on pharmacy ownership E-10-2026-000645Written questionwith 2 co-authors26 Mar 2026
11 Feb 2026Protecting allergic consumers by harmonising EU ingredient labelling E-10-2026-000591Written questionwith 5 co-authors17 Apr 2026
9 Feb 2026MOTION FOR A RESOLUTION on World Cancer Day B-10-2026-0141Motion for a resolutionwith 18 co-authors—
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026

Show all 29 questions and motions

Amendments tabled in committee, 114

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT21
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT35
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT5
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT8
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791073 CJ722
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791874 CJ722
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791873 CJ7219
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ537
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ538

Show all 114 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Poland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Adam JARUBAS”. Member record. memberId 197517. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197517?page=12&rows=all&scope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197517?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197517,
  author = {{EU Parl Watch Research}},
  title = {{Adam JARUBAS}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197517?page=12&rows=all&scope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/197517?page=12&rows=all&scope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197517. Official source: https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}